T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCR
1526
DELISTED
OMNICARE INC
OCR
| $2.98M | ﹤0.01% |
31,616
+110
| +0.3% | +$9.81K |
|
1527
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $2.96M | ﹤0.01% |
107,950
-91,320
| -46% | -$2.66M |
|
1528
John Wiley & Sons Class A
WLY
$2.63B
| $2.92M | ﹤0.01% |
53,670
-4,800
| -8% | -$279K |
|
|
AGTC
1529
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.91M | ﹤0.01% |
189,981
-18,254
| -9% | -$350K |
|
|
JAH
1530
DELISTED
JARDEN CORPORATION
JAH
| $2.91M | ﹤0.01% |
56,259
+1,873
| +3% | +$99.1K |
|
1531
Unisys
UIS
$210M
| $2.9M | ﹤0.01% |
145,139
-11,200
| -7% | -$241K |
|
|
CETV
1532
DELISTED
Central European Media Enterprises Ltd
CETV
| $2.9M | ﹤0.01% |
1,328,700
| – | – |
|
|
LDRH
1533
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $2.9M | ﹤0.01% |
66,958
-91,945
| -58% | -$3.65M |
|
1534
UDR
UDR
$12.2B
| $2.87M | ﹤0.01% |
89,582
+1,398
| +2% | +$45.9K |
|
1535
Rio Tinto
RIO
$160B
| $2.86M | ﹤0.01% |
69,390
+4,000
| +6% | +$176K |
|
1536
HF Sinclair
DINO
$16.3B
| $2.84M | ﹤0.01% |
66,546
| – | – |
|
|
TLN
1537
DELISTED
Talen Energy Corporation
TLN
| $2.8M | ﹤0.01% |
+163,384
| New | +$3.08M |
|
1538
SiriusXM
SIRI
$9.43B
| $2.75M | ﹤0.01% |
73,689
-5,266
| -7% | -$204K |
|
|
SUNE
1539
DELISTED
SUNEDISON, INC COM
SUNE
| $2.74M | ﹤0.01% |
91,600
+3,700
| +4% | +$105K |
|
1540
Heartland Express
HTLD
$979M
| $2.72M | ﹤0.01% |
134,334
-3,985
| -3% | -$85.5K |
|
|
FRC
1541
DELISTED
First Republic Bank
FRC
| $2.69M | ﹤0.01% |
42,748
+144
| +0.3% | +$8.71K |
|
|
SGY
1542
DELISTED
Stone Energy
SGY
| $2.69M | ﹤0.01% |
3,763
-658
| -15% | -$559K |
|
1543
Modine Manufacturing
MOD
$10.8B
| $2.62M | ﹤0.01% |
244,200
-2,053,950
| -89% | -$24.6M |
|
1544
Lear
LEA
$8.16B
| $2.59M | ﹤0.01% |
23,100
+800
| +4% | +$91.9K |
|
|
FIT
1545
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.59M | ﹤0.01% |
+67,750
| New | +$2.38M |
|
|
GXP
1546
DELISTED
Great Plains Energy Incorporated
GXP
| $2.56M | ﹤0.01% |
105,798
| – | – |
|
1547
Sociedad Química y Minera de Chile
SQM
$20.6B
| $2.54M | ﹤0.01% |
162,882
-600,799
| -79% | -$11.5M |
|
1548
Arthur J. Gallagher & Co
AJG
$65B
| $2.49M | ﹤0.01% |
52,560
+5,600
| +12% | +$270K |
|
1549
Extra Space Storage
EXR
$31.6B
| $2.43M | ﹤0.01% |
37,200
| – | – |
|
1550
Everest Group
EG
$14B
| $2.4M | ﹤0.01% |
13,163
+57
| +0.4% | +$10.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.